Precise, CRISPR-mediated integration of target genes into the C. glutamicum genome, with marker-free integration available when scoped.
Our service enables stable integration of heterologous genes or expression cassettes into the Corynebacterium glutamicum chromosome, facilitating long-term production without plasmid dependence. We handle strain evaluation, donor design, transformation, and rigorous clone screening. Deliverables include sequence-verified constructs and confirmed engineered strains as scoped, with data supporting downstream characterization and scale-up evaluation.
Work with C. glutamicum ATCC 13032, ATCC 13869, or client-provided strains. Suitability for the intended use is assessed for the final strain and product.
From single-gene knock-in to multi-locus integration. Screening depth and scope are defined per project.
QC includes serial passaging and re-sequencing to investigate genetic stability of the engineered strain.
All materials and data from your knock-in project, tailored to the agreed scope.
| Parameter | Typical project scope |
|---|---|
| Target Strain | C. glutamicum GRAS strains (ATCC 13032, ATCC 13869, or client-provided isolate) |
| Gene of Interest (GOI) Size | Scoped per project after consultation |
| Homology Arm Length | Scoped per project after consultation |
| Marker Integration | Marker-free or antibiotic marker (kanamycin resistance, chloramphenicol resistance) as selected |
| Clone Screening Depth | Typically 24–96 colonies; can be increased per project |
| Integration Locus | Intergenic site (e.g., cg1121-cg1122) or specific locus as requested |
A streamlined, five-step process from design to validated strain.
We review your target gene sequence, intended integration locus, and strain background. Guide RNAs are designed for the site, and homology arm boundaries are defined based on genomic context.
Donor template containing the gene of interest with homology arms is synthesized and cloned into a delivery vector. Guide RNA expression cassettes are assembled and verified by sequencing.
C. glutamicum competent cells are prepared and co-transformed with the donor and CRISPR plasmids. Colonies are selected on appropriate antibiotics or marker recovery plates.
Candidate clones are screened by colony PCR spanning both integration junctions. Positive clones are verified by Sanger sequencing to confirm the intended sequence and junctions; expression requires a separate readout.
Verified clones are streak-purified to single colonies. Glycerol stocks are prepared, and a final QC panel including junction PCR, sequencing, and optional stability passaging is completed.
Stable gene integration supports a range of industrial and research uses.
Knock-in of key enzymes or transporters to evaluate production of lysine, glutamate, or other amino acids.
Integrate genes for industrial enzymes, therapeutic proteins, or biosensors into the C. glutamicum chromosome.
Combine multiple knock-ins for complex metabolic rewiring, including co-factor regeneration and byproduct elimination.
Common concerns about our C. glutamicum knock-in service.
Insert size depends on the donor design and strain. The feasible insert size is evaluated during project design. Larger fragments may require case-by-case optimization; we evaluate during the design phase and propose the best strategy.
Yes. We offer marker-free integration using counter-selectable markers (e.g., sacB) or Cre-lox recombination. This allows for subsequent rounds of genome editing without retained antibiotic markers. Marker-free strains are available as an option scoped per project.
Integration is confirmed by colony PCR amplifying across both 5′ and 3′ junctions, followed by Sanger sequencing of the entire inserted region and flanking genomic DNA.
Project timelines are confirmed during scoping and cover design, construction, transformation, screening, and QC.
Get a customized quote for your Corynebacterium glutamicum Gene Knock-in project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.